Aanal B.

About Aanal B.

I am a Platform Scientist with over 7 years of experience architecting HTS pipelines that bridge complex biology and robotic automation. By scaling workflows to members weekly and publishing on AI/ML-driven developability in mAbs (2025), I specialize in delivering high-fidelity, model-ready datasets for discovery programs. My focus is on driving therapeutic innovation through high-integrity, automated platforms.

Experience

1. Scientist, Antibody Developability

   Ginkgo Bioworks

   Mar 2024 — Present · Boston, MA, US

   As a platform scientist on the Ginkgo Datapoints team, I lead the design, execution, and continuous improvement of high-throughput antibody developability workflows for external pharmaceutical partners- Designed and launched a polyreactivity (PR) assay platform now adopted by ~100% of external customers, including successful high-throughput pilots with multiple top-tier global pharma partners — establishing it as a core commercial offering for Ginkgo Datapoints- Currently overseeing a large-scale developability screening campaign (Polyreactivity, AC SINS) processing 15,600+ samples per assay for a major pharmaceutical partner, with full ownership of workflow execution, QC decision-making, and data delivery- Defined platform-level pass/fail logic, QC thresholds, and standardized Spotfire dashboards to ensure reproducible, audit-ready data handling across high-visibility screening campaigns- Served as technical lead and mentor for the team, driving development of 384-well BVP ELISA, AC-SINS, and polyreactivity assays and building team-wide capacity through coaching and delegation.

Education

• Harvard University

  Semester Abroad Program, Biology/Biological Sciences, General

• University of Southern California

  Master of Science - MS, Stem Cell Biology and Regenerative Medicine

  2017 — 2018

• SRM IST Chennai

  Bachelor of Technology (B.Tech.), Biotechnology

  2013 — 2017